Trademark Details For MICROINGREDIENTS IMMUNE SUPPORT · EXTRA STRENGTH · K2 AS MK-7 VITAMIN D3 & K2 10,000 IU + 200 MCG MADE WITH COCONUT OIL (Serial Number 98608038)

  •  Home
  •  Print
MICROINGREDIENTS IMMUNE SUPPORT · EXTRA STRENGTH · K2 AS MK-7 VITAMIN D3 & K2 10,000 IU + 200 MCG MADE WITH COCONUT OIL
0
0
0
0
Serial Number  United States - USPTO 98608038
Registration Number -
Mark
MICROINGREDIENTS IMMUNE SUPPORT · EXTRA STRENGTH · K2 AS MK-7 VITAMIN D3 & K2 10,000 IU + 200 MCG MADE WITH COCONUT OIL
Filing Date Jun-19-2024
Status
Pending  
NON-FINAL AC.. (641)
NON-FINAL ACTION - MAILED
Attorney Name
TTAB
0



  • Description Of Mark:
  • Color(s) Claimed:

005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Jan-08-2017

First Use in Commerce: Jan-08-2017


05.09.13
05.09.25
10.09.01
26.01.02
26.01.05
26.01.08



Correspondences

NameXiuyuan Hu Hu LLP
Address980 ROOSEVELT, STE 110 Irvine, CA 92620 United States

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jun-19-2024NEW APPLICATION ENTERED   NWAPI
Feb-21-2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Feb-21-2025NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSCE
Feb-22-2025ASSIGNED TO EXAMINER   DOCKD
Feb-26-2025NON-FINAL ACTION WRITTEN   CNRTR
Feb-26-2025NON-FINAL ACTION E-MAILED   GNRTF
Feb-26-2025NOTIFICATION OF NON-FINAL ACTION E-MAILED   GNRNO
May-09-2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED   XELRI
May-09-2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED   XELGO
Aug-22-2025TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Aug-22-2025CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Aug-22-2025TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Aug-26-2025NON-FINAL ACTION WRITTEN   CNRTR
Aug-26-2025NON-FINAL ACTION E-MAILED   GNRTF
Aug-26-2025NOTIFICATION OF NON-FINAL ACTION E-MAILED   GNRNO
Nov-22-2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED   XELRI
Nov-22-2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED   XELGO